| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/07/2026 | ±1.6% | +0.7% | over-priced |
| 06/03/2026 | ±2.6% | +0.8% | over-priced |
| 03/11/2026 | ±2.4% | -0.5% | over-priced |
| 12/17/2025 | ±2.5% | +0.3% | over-priced |
| 10/08/2025 | ±1.2% | +0.0% | over-priced |
| 06/05/2025 | ±2.3% | -3.9% | under-priced |
| 03/13/2025 | ±4.1% | -3.9% | over-priced |
| 12/19/2024 | ±2.4% | -1.0% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2026 | — | $95.7B | $3.0B |
| Q3 FY2026 | $4.93 | $70.5B | $2.2B |
| Q2 FY2026 | $4.58 | $69.6B | $2.0B |
| Q1 FY2026 | $4.50 | $67.3B | $2.0B |
COST (COST) reports in 71 days, with the next report estimated for 01/06/2027. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced COST's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 11.1%. QuantLogix's live 5-factor engine currently reads COST as a buy at 73/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →